2BB score and signals
Enliven Therapeutics, Inc.’s current 2BB score is 31 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 52 | Moderate |
| Momentum | 47 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 44 | Moderate |
Company facts
| Headquarters | Boulder, Colorado, United States |
| Founded | 2016 |
| Employees | 67 |
| 52-week range | $14.78 – $62.32 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.4529 | — | $0.00 |
| 2026-08-19 | — | -0.4062 | — | $0.00 |
| 2026-05-07 | -0.38 | -0.472 | $0.00 | $0.00 |
| 2026-03-03 | -0.48 | -0.3853 | $0.00 | $8,496.00 |
Related companies
2BBBullish & Bearish